Evidence map›Paper›PMID 37089889›Full record

ArticleFrontiers in cardiovascular medicine2023

Study on the process of cardiomyocyte apoptosis after pulsed field ablation.

Shaobo Fan, Fenglin Jia, Yingjian Cui, Dongyan Wu, Le He, Fan Zhang, Zhixiao Xue, Xinyu Xu, Fengmin Lu, Wei Ma and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Opportunities and Challenges in Catheter-Based Irreversible Electroporation for Ventricular Tachycardia.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Shaobo FanDepartment of Cardiology, Chest Hospital, Tianjin University, Tianjin, China.
Fenglin JiaSchool of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China.
Yingjian CuiSchool of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China.
Dongyan WuDepartment of Cardiology, Chest Hospital, Tianjin University, Tianjin, China.
Le HeDepartment of Cardiology, Chest Hospital, Tianjin University, Tianjin, China.
Fan ZhangDepartment of Cardiology, Chest Hospital, Tianjin University, Tianjin, China.
Zhixiao XueSchool of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China.
Xinyu XuSchool of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China.
Fengmin LuDepartment of Cardiology, Chest Hospital, Tianjin University, Tianjin, China.
Wei MaDepartment of Cardiology, Chest Hospital, Tianjin University, Tianjin, China.
Siying SuDepartment of Research and Development, Tianjin Intelligent Health Medical Co., Ltd, Tianjin, China.
Yanpeng ChenDepartment of Research and Development, Tianjin Intelligent Health Medical Co., Ltd, Tianjin, China.
Zhenxu LiuDepartment of Research and Development, Tianjin Intelligent Health Medical Co., Ltd, Tianjin, China.
Tianjin Chest Hospital · CNTianjin Medical University · CNTianjin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The development of pulsed field ablation (PFA) as a new technique for pulmonary vein isolation (PVI) has been advancing rapidly in recent years. My team's previous work has shown the safety and long-term efficacy of bipolar asymmetric pulses in animal experiments. However, in ongoing clinical trials, we have observed that atrial fibrillation (AF) recurs in some patients after surgery, but the rhythm returns to normal without surgical intervention after seven days, and there is no recurrence in the follow-up.Based on this observation, we have proposed the hypothesis that myocardial cell apoptosis may play a role in AF recurrence after PFA. Our team has designed animal experiments to verify this hypothesis and further investigate the process of PFA-induced cardiomyocyte apoptosis. Methods: Pulse field ablation was performed on 15 dogs and the animals were dissected at various time points after the operation (immediately, 3 days, 7 days, 30 days, and 150 days). To obtain ablation voltage maps, electroanatomic mapping was performed before and after ablation and before dissection. The ablation area was also subjected to HE and TUNEL staining to analyze apoptosis and pathological results. Results: The edge area of the ablation in the pulmonary vein (PV) demonstrated continuous dynamic changes from 0 to 2 h after the operation and a slight expansion of the ablation range was observed in the long-term follow-up. Myocardial intima hyperplasia was observed from 0 to 7 days. Local apoptosis was detected from 0 to 2 h and massive, concentrated apoptosis was observed at 3 days. No recurrence of apoptosis was seen at 7 days, 30 days, and 150 days. Conclusions: The results of this study showed that after pulse field ablation (PFA), the central ablation area of the canine heart experienced immediate cardiomyocyte death. Meanwhile, cardiomyocytes in the edge ablation area underwent apoptosis, which began from 0 to 2 h post-operation and ended between 3 and 7 days. This process occurred simultaneously with intimal thickening.In the long-term follow-up group, there was no recovery of isolation and no recurrence of cardiomyocyte apoptosis, and no change was observed in the endomyocardial intima.

Indexed as

atrial fibrillationcardiac ablationmyocardiocytepulmonary vein isolationpulse field ablation

Identifiers

PMID37089889
PMCPMC10113644
OpenAlexW4362623248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.